Modeling Glioma Stem Cell-Mediated Tumorigenesis Using Zebrafish Patient-Derived Xenograft Systems

Area of Science:

• Oncology
• Stem Cell Biology
• Zebrafish Models

Background:

• Glioblastoma (GBM) is an aggressive brain tumor characterized by high recurrence rates and poor survival.
• Tumor heterogeneity, driven by glioma stem cells (GSCs), contributes to GBM's aggressive nature and resistance to therapy.
• Understanding GSC behavior within the tumor microenvironment (TME) is crucial for developing effective treatments.

Purpose of the Study:

• To describe methods for generating zebrafish (Danio rerio) patient-derived xenografts (PDXs).
• To establish a relevant experimental system for studying GSC-mediated tumorigenesis and TME interactions.
• To provide a viable alternative to traditional mouse models for GBM research.

Main Methods:

• Generation of patient-derived xenografts (PDXs) using zebrafish embryos.
• Inoculation of human glioblastoma cells into the zebrafish model.
• Observation and analysis of tumor growth and GSC behavior within the zebrafish TME.

Main Results:

• Zebrafish PDXs successfully recapitulate key aspects of human GBM, including heterogeneity and GSC populations.
• The model allows for dynamic visualization of GSC interactions with the TME.
• This system proves to be time- and cost-efficient compared to mouse models.

Conclusions:

• Zebrafish PDXs provide a robust and reproducible platform for studying glioblastoma and glioma stem cells.
• This model facilitates the investigation of GSC-driven tumorigenesis and therapeutic resistance mechanisms.
• Zebrafish xenografts represent a valuable tool for advancing GBM research and identifying novel treatment strategies.